P63 Patient-Reported Outcomes Following Treatment with Vimseltinib for Tenosynovial Giant Cell Tumour in a Phase 2 Expansion Study
Blay, JY, Gelderblom, H, Rutkowski, P, Wagner, AJ, van de Sande, M, Stacchiotti, S, Le Cesne, A, Palmerini, E, Vallee, M, Harrow, B, Becker, C, Jarecha, R, Sharma, M, Tap, WD
Published in Value in health (01.12.2022)
Published in Value in health (01.12.2022)
Get full text
Journal Article
1509P Efficacy and safety of vimseltinib in tenosynovial giant cell tumour (TGCT): Phase II expansion
Blay, J-Y., Gelderblom, H., Rutkowski, P., Wagner, A., van de Sande, M., Falcon Gonzalez, A., Stacchiotti, S., Le Cesne, A., Alcindor, T., Serrano, C., Palmerini, E., Ravi, V., Casado Herraez, A., Seddon, B., Vallee, M., Jarecha, R., Sharma, M., Ruiz-Soto, R., Sherman, M.L., Tap, W.D.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article